BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 35616069)

  • 1. Walnut green husk ethanol extract improves gut microbiota and their metabolites associated with NLRP3 in non-alcoholic steatohepatitis.
    Fang Q; Li X; Wang M; Qiao X; Huang F; Hu C; Xue Y; Zhao S; Lin Y
    Food Funct; 2022 Jun; 13(11):6387-6403. PubMed ID: 35616069
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of Tylophora yunnanensis Schltr on regulating the gut microbiota and its metabolites in non-alcoholic steatohepatitis rats by inhibiting the activation of NOD-like receptor protein 3.
    Lin YP; Fang QL; Xue YM; Fu SN; Hu CY; Huang F; Wang MM; Qiao X; Yin XQ; Zeng YC; Du CH; Zhao XJ; Li XP; Hua Y
    J Ethnopharmacol; 2023 Apr; 305():116145. PubMed ID: 36623753
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The alleviating effect of
    Lin YP; Fang QL; Fu SN; Li XP; Shi R; Du CH; Qiao X; Yin XQ; Zeng YC; Zhao XJ; Hua Y
    Front Pharmacol; 2023; 14():1143785. PubMed ID: 38026986
    [No Abstract]   [Full Text] [Related]  

  • 4. Structural modulation of gut microbiota during alleviation of non-alcoholic fatty liver disease with Gynostemma pentaphyllum in rats.
    Shen SH; Zhong TY; Peng C; Fang J; Lv B
    BMC Complement Med Ther; 2020 Feb; 20(1):34. PubMed ID: 32024509
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Absence of the Caspases 1/11 Modulates Liver Global Lipid Profile and Gut Microbiota in High-Fat-Diet-Induced Obese Mice.
    de Sant'Ana LP; Ribeiro DJS; Martins AMA; Dos Santos FN; Corrêa R; Almeida RDN; Eberlin MN; Maurice CF; Magalhães KG
    Front Immunol; 2019; 10():2926. PubMed ID: 31998283
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sodium Alginate Prevents Non-Alcoholic Fatty Liver Disease by Modulating the Gut-Liver Axis in High-Fat Diet-Fed Rats.
    Zhao H; Gao X; Liu Z; Zhang L; Fang X; Sun J; Zhang Z; Sun Y
    Nutrients; 2022 Nov; 14(22):. PubMed ID: 36432531
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anti-NAFLD effect of defatted walnut powder extract in high fat diet-induced C57BL/6 mice by modulating the gut microbiota.
    Ren SM; Zhang QZ; Chen ML; Jiang M; Zhou Y; Xu XJ; Wang DM; Pan YN; Liu XQ
    J Ethnopharmacol; 2021 Apr; 270():113814. PubMed ID: 33444725
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effects of Atractylodes macrocephala extract BZEP self-microemulsion based on gut-liver axis HDL/LPS signaling pathway to ameliorate metabolic dysfunction-associated fatty liver disease in rats.
    Li B; Jiang XF; Dong YJ; Zhang YP; He XL; Zhou CL; Ding YY; Wang N; Wang YB; Cheng WQ; Jiang NH; Su J; Lv GY; Chen SH
    Biomed Pharmacother; 2024 Jun; 175():116519. PubMed ID: 38663104
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pure total flavonoids from citrus attenuate non-alcoholic steatohepatitis via regulating the gut microbiota and bile acid metabolism in mice.
    He B; Jiang J; Shi Z; Wu L; Yan J; Chen Z; Luo M; Cui D; Xu S; Yan M; Zhang S; Chen Z
    Biomed Pharmacother; 2021 Mar; 135():111183. PubMed ID: 33401222
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sodium butyrate attenuates high-fat diet-induced steatohepatitis in mice by improving gut microbiota and gastrointestinal barrier.
    Zhou D; Pan Q; Xin FZ; Zhang RN; He CX; Chen GY; Liu C; Chen YW; Fan JG
    World J Gastroenterol; 2017 Jan; 23(1):60-75. PubMed ID: 28104981
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Paeonol attenuates nonalcoholic steatohepatitis by regulating intestinal flora and AhR/NLRP3/Caspase-1 metabolic pathway.
    Yan G; Zhang L; Wu D; Jiang S; Wu Q; Dai M
    J Ethnopharmacol; 2024 Jul; 329():118147. PubMed ID: 38574779
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hepatoprotective Effects of
    Jin W; Cho S; Laxi N; Bao T; Dai L; Yu H; Qi R; Zhang J; Ba G; Fu M
    Molecules; 2022 May; 27(10):. PubMed ID: 35630624
    [No Abstract]   [Full Text] [Related]  

  • 13. The protective effects of walnut green husk polysaccharide on liver injury, vascular endothelial dysfunction and disorder of gut microbiota in high fructose-induced mice.
    Wang G; Zhang Y; Zhang R; Pan J; Qi D; Wang J; Yang X
    Int J Biol Macromol; 2020 Nov; 162():92-106. PubMed ID: 32531370
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Salidroside improves high-fat diet-induced non-alcoholic steatohepatitis by regulating the gut microbiota-bile acid-farnesoid X receptor axis.
    Li H; Xi Y; Xin X; Tian H; Hu Y
    Biomed Pharmacother; 2020 Apr; 124():109915. PubMed ID: 31986416
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Folic acid attenuates high-fat diet-induced steatohepatitis
    Xin FZ; Zhao ZH; Zhang RN; Pan Q; Gong ZZ; Sun C; Fan JG
    World J Gastroenterol; 2020 May; 26(18):2203-2220. PubMed ID: 32476787
    [TBL] [Abstract][Full Text] [Related]  

  • 16.
    Yue SR; Tan YY; Zhang L; Zhang BJ; Jiang FY; Ji G; Liu BC; Wang RR
    Front Endocrinol (Lausanne); 2022; 13():885039. PubMed ID: 35937847
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lingguizhugan decoction improves non-alcoholic steatohepatitis partially by modulating gut microbiota and correlated metabolites.
    Zhu M; Wang X; Wang K; Zhao Z; Dang Y; Ji G; Li F; Zhou W
    Front Cell Infect Microbiol; 2023; 13():1066053. PubMed ID: 36779187
    [TBL] [Abstract][Full Text] [Related]  

  • 18. GW9662 ameliorates nonalcoholic steatohepatitis by inhibiting the PPARγ/CD36 pathway and altering the gut microbiota.
    Xiao J; Xiang H; Xiang H; Sun Z; Xu J; Ren H; Hu P; Peng M
    Eur J Pharmacol; 2023 Dec; 960():176113. PubMed ID: 37838102
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Walnut Meal Extracts Rich In Polyphenols Mitigate Insulin Resistance and Modulate Gut Microbiota in High Fat Diet-Fed Rats.
    He X; Chen D; Guo Y; Zhang X; Ma Y; Zhao S
    J Med Food; 2022 Jun; 25(6):618-629. PubMed ID: 35708635
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of NLRP3 inflammasome by thioredoxin-interacting protein in mouse Kupffer cells as a regulatory mechanism for non-alcoholic fatty liver disease development.
    He K; Zhu X; Liu Y; Miao C; Wang T; Li P; Zhao L; Chen Y; Gong J; Cai C; Li J; Li S; Ruan XZ; Gong J
    Oncotarget; 2017 Jun; 8(23):37657-37672. PubMed ID: 28499273
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.